Research > ETFs > ETF / ETP Commentary > 

BlackRock Looks to Challenge QQQ With New Nasdaq-100 ETF

On Thursday, July 9, BlackRock debuted the iShares Nasdaq 100 ETF (IQQ). IQQ marks a significant inflection point in the ETF market, as BlackRock looks to challenge the tried-and-true Invesco QQQ Trust Series I (QQQ B).Key Takeaways: BlackRock has launched the iShares Nasdaq 100 ETF (IQQ), a fund that provides targeted exposure to companies within the Nasdaq-100. IQQ joins the State Street SPDR Portfolio Nasdaq 100 ETF (QNDX) as the second fund to challenge Invesco’s QQQ. QQQ continues to post strong annual results, especially after the fund announced structural adjustments at the end of 2025. As one may expect, IQQ looks to provide focused exposure to the Nasdaq-100. This index has historically offered compelling access to companies within the tech, consumer discretionary, healthcare, and industrials sectors.  “IQQ enhances our ability to offer investors access to the Nasdaq-100 with iShares ETFs — providing complementary strategies that allow them to align their portfolios with their objectives,” said Elise Terry, U.S. Head of iShares at BlackRock. “Supported by the liquidity, market quality, and scale of the iShares platform, this expanded suite gives investors the flexibility to customize their exposures and evolve portfolios over time.” See More: Why Pure-Play Healthcare Technology Innovation Matters Part of how IQQ aims to challenge QQQ’s long-standing dominance is through its expense ratio. IQQ usually operates with an expense ratio of 12 basis points, and is temporarily running a waiver that reduces that to 10 basis points. Amping Up The CompetitionBlackRock is not the first firm to go to bat against the Q’s. Back in June, State Street also launched the State Street SPDR Portfolio Nasdaq 100 ETF (QNDX), which likewise provides distinct access to the Nasdaq-100.  See More: State Street Goes Heads Up With Qs, Launches Nasdaq 100 ETF It’s certainly worth noting that QQQ is currently posting highly impressive results. As of June 29, 2026, the fund has a 1-year cumulative return of 33.98%.  This comes after Invesco announced a number of changes to QQQ’s structure at the end of 2025. The restructuring included shifting the format from a unit investment trust into an open-ended ETF and lowering the fund’s fee by two basis points. Consequently, long-term QQQ investors will likely stick with the strategy despite new competition. That being said, competition can also breed innovation. Advisors and investors would be wise to keep an eye on all three ETFs in the weeks and months to come. Considering that the Nasdaq-100’s tech tilt taps into a number of favorable trends, such as artificial intelligence (AI), these funds could offer potent positions within a multitude of portfolios.  For more news, information, and analysis, visit the Equity ETF Content Hub.

Performance data shown is past performance and is no guarantee of future results. Current performance may be higher or lower than the performance data quoted. Yield and return will vary, therefore you have a gain or loss when you sell your shares. For standard quarterly performance, go to the fund's Snapshot page by clicking on the ETF/ETP's symbol.

ETFs may trade at a premium or discount to their NAV and are subject to the market fluctuations of their underlying investments.

For iShares ETFs, Fidelity receives compensation from the ETF sponsor and/or its affiliates in connection with an exclusive long-term marketing program that includes promotion of iShares ETFs and inclusion of iShares funds in certain FBS platforms and investment programs. Please note, this security will not be marginable for 30 days from the settlement date, at which time it will automatically become eligible for margin collateral. Additional information about the sources, amounts, and terms of compensation can be found in the ETF's prospectus and related documents. Fidelity may add or waive commissions on ETFs without prior notice. BlackRock and iShares are registered trademarks of BlackRock, Inc. and its affiliates.

FBS receives compensation from the fund's advisor or its affiliates in connection with a marketing program that includes the promotion of this security and other ETFs to customers ("Marketing Program"). The Marketing Program creates incentives for FBS to encourage the purchase of certain ETFs. Additional information about the sources, amounts, and terms of compensation is in the ETF's prospectus and related documents. Please note that this security will not be marginable for 30 days from the settlement date, at which time it will automatically become eligible for margin collateral.

News, commentary (including "Related Symbols") and events are from third-party sources unaffiliated with Fidelity. Fidelity does not endorse or adopt their content. Fidelity makes no guarantees that information supplied is accurate, complete, or timely, and does not provide any warranties regarding results obtained from their use.

Any data, charts and other information provided on this page are intended to help self-directed investors evaluate exchange traded products (ETPs), including, but limited to exchange traded funds (ETFs) and exchange traded notes (ETNs). Criteria and inputs entered, including the choice to make ETP comparisons, are at the sole discretion of the user and are solely for the convenience of the user. Analyst opinions, ratings and reports are provided by third-parties unaffiliated with Fidelity. All information supplied or obtained from this page is for informational purposes only and should not be considered investment advice or guidance, an offer of or a solicitation of an offer to buy or sell a particular security, or a recommendation or endorsement by Fidelity of any security or investment strategy. Fidelity does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating ETPs. Fidelity makes no guarantees that information supplied is accurate, complete, or timely, and does not provide any warranties regarding results obtained from their use. Determine which securities are right for you based on your investment objectives, risk tolerance, financial situation and other individual factors and re-evaluate them on a periodic basis.

Before investing in any exchange traded product, you should consider its investment objective, risks, charges and expenses. Contact Fidelity for a prospectus, offering circular or, if available, a summary prospectus containing this information. Read it carefully.